PD-L1 expression in tumor infiltrated lymphocytes predicts survival in triple-negative breast cancer

ConclusionPD-L1 expression in TILs,but not in tumor cells,was a poor prognostic factor in TNBC. These data provide further impetus for assessing immunotherapy in TNBC, in view of the clinical significance of the expression of PD-L1(SP142) in TNBC.
Source: Pathology Research and Practice - Category: Pathology Source Type: research